Immunogenicity of COVID-19 Vaccinations in Hematological Patients: 6-Month Follow-Up and Evaluation of a 3rd Vaccination

Immunogenicity of COVID-19 Vaccinations in Hematological Patients: 6-Month Follow-Up and Evaluation of a 3rd Vaccination

Here we analyzed SARS-CoV-2-specific antibodies and T-cell responses after two coronavirus disease 2019 vaccinations over a six-month period in patients with hematological malignancies and assessed the effect of a third vaccination in a subgroup. Sixty-six patients and 66 healthy controls were inclu...

Full description

Bibliographic Details
Main Authors: Aberle, J.H (Author), Blüml, S. (Author), Burgmann, H. (Author), Haslacher, H. (Author), Jaeger, U. (Author), Koblischke, M. (Author), Porpaczy, E. (Author), Schneider, L. (Author), Schubert, L. (Author), Tobudic, S. (Author), Winkler, F. (Author), Winkler, S. (Author)
Format: Article
Language:English
Published: MDPI 2022
Subjects:
clinical trials
COVID-19
hematology–general
vaccine
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items